461 related articles for article (PubMed ID: 22249261)
1. Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma.
Fatima S; Lee NP; Tsang FH; Kolligs FT; Ng IO; Poon RT; Fan ST; Luk JM
Oncogene; 2012 Sep; 31(38):4233-44. PubMed ID: 22249261
[TBL] [Abstract][Full Text] [Related]
2. Dickkopf 4 positively regulated by the thyroid hormone receptor suppresses cell invasion in human hepatoma cells.
Liao CH; Yeh CT; Huang YH; Wu SM; Chi HC; Tsai MM; Tsai CY; Liao CJ; Tseng YH; Lin YH; Chen CY; Chung IH; Cheng WL; Chen WJ; Lin KH
Hepatology; 2012 Mar; 55(3):910-20. PubMed ID: 21994129
[TBL] [Abstract][Full Text] [Related]
3. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.
Qin X; Zhang H; Zhou X; Wang C; Zhang H; Zhang X; Ye L
Transl Res; 2007 Nov; 150(5):281-94. PubMed ID: 17964517
[TBL] [Abstract][Full Text] [Related]
4. Glucose induced activation of canonical Wnt signaling pathway in hepatocellular carcinoma is regulated by DKK4.
Chouhan S; Singh S; Athavale D; Ramteke P; Pandey V; Joseph J; Mohan R; Shetty PK; Bhat MK
Sci Rep; 2016 Jun; 6():27558. PubMed ID: 27272409
[TBL] [Abstract][Full Text] [Related]
5. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
Lu WJ; Chua MS; Wei W; So SK
Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
[TBL] [Abstract][Full Text] [Related]
6. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
Cheng AS; Lau SS; Chen Y; Kondo Y; Li MS; Feng H; Ching AK; Cheung KF; Wong HK; Tong JH; Jin H; Choy KW; Yu J; To KF; Wong N; Huang TH; Sung JJ
Cancer Res; 2011 Jun; 71(11):4028-39. PubMed ID: 21512140
[TBL] [Abstract][Full Text] [Related]
7. UNC119 promoted cell growth and migration by Wnt/β-catenin signal and TGF-β/EMT signal pathway in hepatocellular carcinoma.
Liu ZH; Zhang YF; Xu ZD; Z H L; Y F Z; Z D X
J BUON; 2018; 23(6):1717-1724. PubMed ID: 30610799
[TBL] [Abstract][Full Text] [Related]
8. The effects of Dickkopf-4 on the proliferation, differentiation, and apoptosis of osteoblasts.
Hiramitsu S; Terauchi M; Kubota T
Endocrinology; 2013 Dec; 154(12):4618-26. PubMed ID: 24105477
[TBL] [Abstract][Full Text] [Related]
9. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
Ma L; Wang X; Jia T; Wei W; Chua MS; So S
Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
[TBL] [Abstract][Full Text] [Related]
10. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
[TBL] [Abstract][Full Text] [Related]
11. CUL4B activates Wnt/β-catenin signalling in hepatocellular carcinoma by repressing Wnt antagonists.
Yuan J; Han B; Hu H; Qian Y; Liu Z; Wei Z; Liang X; Jiang B; Shao C; Gong Y
J Pathol; 2015 Apr; 235(5):784-95. PubMed ID: 25430888
[TBL] [Abstract][Full Text] [Related]
12. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.
Peng YY; He YH; Chen C; Xu T; Li L; Ni MM; Meng XM; Huang C; Li J
Cancer Lett; 2016 Jun; 376(1):10-21. PubMed ID: 26975630
[TBL] [Abstract][Full Text] [Related]
13. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.
Yamashita T; Budhu A; Forgues M; Wang XW
Cancer Res; 2007 Nov; 67(22):10831-9. PubMed ID: 18006828
[TBL] [Abstract][Full Text] [Related]
14. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma.
Tsao CM; Yan MD; Shih YL; Yu PN; Kuo CC; Lin WC; Li HJ; Lin YW
Hepatology; 2012 Dec; 56(6):2277-87. PubMed ID: 22767186
[TBL] [Abstract][Full Text] [Related]
15. GATA5 inhibits hepatocellular carcinoma cells malignant behaviours by blocking expression of reprogramming genes.
Feng H; Zhu M; Zhang R; Wang Q; Li W; Dong X; Chen Y; Lu Y; Liu K; Lin B; Guo J; Li M
J Cell Mol Med; 2019 Apr; 23(4):2536-2548. PubMed ID: 30672133
[TBL] [Abstract][Full Text] [Related]
16. Bruceine D inhibits hepatocellular carcinoma growth by targeting β-catenin/jagged1 pathways.
Cheng Z; Yuan X; Qu Y; Li X; Wu G; Li C; Zu X; Yang N; Ke X; Zhou J; Xie N; Xu X; Liu S; Shen Y; Li H; Zhang W
Cancer Lett; 2017 Sep; 403():195-205. PubMed ID: 28645563
[TBL] [Abstract][Full Text] [Related]
17. 5-Hydroxytryptamine promotes hepatocellular carcinoma proliferation by influencing β-catenin.
Fatima S; Shi X; Lin Z; Chen GQ; Pan XH; Wu JC; Ho JW; Lee NP; Gao H; Zhang G; Lu A; Bian ZX
Mol Oncol; 2016 Feb; 10(2):195-212. PubMed ID: 26474915
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the Wnt/B-catenin/TCF4 pathway using SAGE, genome-wide microarray and promoter analysis: Identification of BRI3 and HSF2 as novel targets.
Kavak E; Najafov A; Ozturk N; Seker T; Cavusoglu K; Aslan T; Duru AD; Saygili T; Hoxhaj G; Hiz MC; Unal DO; Birgül-Iyison N; Ozturk M; Koman A
Cell Signal; 2010 Oct; 22(10):1523-35. PubMed ID: 20538055
[TBL] [Abstract][Full Text] [Related]
19. Spindle and kinetochore-associated protein 2 facilitates the proliferation and invasion of hepatocellular carcinoma via the regulation of Wnt/β-catenin signaling.
Jiang J; Xu B; Zheng Y; Guo X; Chen F
Exp Cell Res; 2020 Oct; 395(1):112181. PubMed ID: 32682011
[TBL] [Abstract][Full Text] [Related]
20. Prickle-1 negatively regulates Wnt/beta-catenin pathway by promoting Dishevelled ubiquitination/degradation in liver cancer.
Chan DW; Chan CY; Yam JW; Ching YP; Ng IO
Gastroenterology; 2006 Oct; 131(4):1218-27. PubMed ID: 17030191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]